Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection

Immunobiology

Volumn 216, Issue 8, 2011, Pages 961-970

  Campos, Nair ^a   Magro, Fernando ^b,d   Castro, Ana Rita ^a   Cabral, Joana ^a   Rodrigues, Pedro ^a   Silva, Ricardo ^a   Appelberg, Rui ^c   Rodrigues, Susana ^d   Lopes, Susana ^d   Macedo, Guilherme ^d   Sarmento, Amélia ^a,c  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Cytokines; IBD; Macrophages; Mycobacterium avium spp. paratuberculosis; Surface receptors

Indexed keywords

CD40 ANTIGEN; CELL SURFACE RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ADULT; AGED; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-23; MACROPHAGES; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959492512     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.01.002     Document Type: Article

References (46)

1. Abubakar I., Myhill D., Aliyu S.H., Hunter P.R. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm. Bowel Dis. 2008, 14:401-410.
2. Anderson C.A., Massey D.C.O., Barrett J.C., Prescott N.J., Tremelling M., Fisher S.A., Gwilliam R., Jacob J., Nimmo E.R., Drummond H., Lees C.W., Onnie C.M., Hanson C., Blaszczyk K., Ravindrarajah R., Hunt S., Varma D., Hammond N., Lewis G., Attlesey H., Watkins N., Ouwehand W., Strachan D., Mcardle W., Lewis C.M., Consortium W.T.C.C., Lobo A., Sanderson J., Jewell D.P., Deloukas P., Mansfield J.C., Mathew C.G., Satsangi J., Parkes M. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009, 136:523-529. e3.
3. Battaglia E., Biancone L., Resegotti A., Emanuelli G., Fronda G.R., Camussi G. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am. J. Gastroenterol. 1999, 94:3279-3284.
4. Browning B.L., Huebner C., Petermann I., Gearry R.B., Barclay M.L., Shelling A.N., Ferguson L.R. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am. J. Gastroenterol. 2007, 102:2504-2512.
5. Clancy R., Ren Z., Turton J., Pang G., Wettstein A. Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-alpha secretion. Dig. Liver Dis. 2007, 39:445-451.
6. Correa I., Veny M., Esteller M., Pique J.M., Yague J., Panes J., Salas A. Defective IL-10 production in severe phenotypes of Crohn's disease. J. Leukocyte Biol. 2009, 85:896-903.
7. Danese S., Sans M., Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 2004, 53:1035-1043.
8. Danese S., Sans M., Scaldaferri F., Sgambato A., Rutella S., Cittadini A., Pique J.M., Panes J., Katz J.A., Gasbarrini A., Fiocchi C. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J. Immunol. 2006, 176:2617-2624.
9. De Jager P.L., Franchimont D., Waliszewska A., Bitton A., Cohen A., Langelier D., Belaiche J., Vermeire S., Farwell L., Goris A., Libioulle C., Jani N., Dassopoulos T., Bromfield G.P., Dubois B., Cho J.H., Brant S.R., Duerr R.H., Yang H., Rotter J.I., Silverberg M.S., Steinhart A.H., Daly M.J., Podolsky D.K., Louis E., Hafler D.A., Rioux J.D., Consortium Q.I.G., Consortium N.I.G. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun. 2007, 8:387-397.
10. Do J.E., Kwon S.Y., Park S., Lee E.-S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford) 2008, 47:840-848.
11. Eastaff-Leung N., Mabarrack N., Barbour A., Cummins A., Barry S. Foxp3(+) regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol. 2009, 30:80-89.
12. Ebert E.C., Panja A., Das K.M., Praveen R., Geng X., Rezac C., Bajpai M. Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies. Clin. Exp. Immunol. 2009, 155:65-71.
13. Feller M., Huwiler K., Stephan R., Altpeter E., Shang A., Furrer H., Pfyffer G., Jemmi T., Baumgartner A., Egger M. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect. Dis. 2007, 7:607-613.
14. Ferwerda G., Kullberg B.J., De Jong D.J., Girardin S.E., Langenberg D.M., Van Crevel R., Ottenhoff T.H., Van Der Meer J.W., Netea M.G. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J. Leukocyte Biol. 2007, 82:1011-1018.
15. Frolova L., Drastich P., Rossmann P., Klimesova K., Tlaskalova-Hogenova H. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J. Histochem. Cytochem. 2008, 56:267-274.
16. Fullen D.R., Headington J.T. Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas. J. Cutan. Pathol. 1998, 25:553-558.
17. Glawischnig W., Steineck T., Spergser J. Infections caused by Mycobacterium avium subspecies avium, hominissuis, and paratuberculosis in free-ranging red deer (Cervus elaphus hippelaphus) in Austria, 2001-2004. J. Wildl. Dis. 2006, 42:724-731.
18. Hölttä V., Klemmetti P., Sipponen T., Westerholm-Ormio M., Kociubinski G., Salo H., Räsänen L., Kolho K.-L., Färkkilä M., Savilahti E., Vaarala O. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm Bowel Dis. 2008, 14:1175-1184.
19. Hue S., Ahern P., Buoncore S., Kullberg M.C., Cua D.J., Mckenzie B.S., Powrie F., Maloy K.J. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006, 203:2473-2483.
20. Judge J., Kyriazakis I., Greig A., Allcroft D.J., Hutchings M.R. Clustering of Mycobacterium avium subsp. paratuberculosis in rabbits and the environment: how hot is a hot spot?. Appl. Environ. Microbiol. 2005, 71:6033-6038.
21. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
22. Li C.-S., Zhang Q., Lee K.-J., Cho S.-W., Lee K.-M., Hahm K.-B., Choi S.-C., Yun K.-J., Chung H.-T., Chae S.-C. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J. Gastroenterol. Hepatol. 2009, 24:1692-1696.
23. Liu Z.-J., Yadav P.-K., Su J.-L., Wang J.-S., Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 2009, 15:5784-5788.
24. Marks D.J.B., Harbord M.W.N., Macallister R., Rahman F.Z., Young J., Al-Lazikani B., Lees W., Novelli M., Bloom S., Segal A.W. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006, 367:668-678.
25. Marrakchi R., Moussa A., Ouerhani S., Bougatef K., Bouhaha R., Messai Y., Rouissi K., Khadimallah I., Khodjet-El-Khil H., Najar T., Benammar-Elgaaeid A. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population. Inflamm. Res. 2009, 58:155-160.
26. Mcclure H.M., Chiodini R.J., Anderson D.C., Swenson R.B., Thayer W.R., Coutu J.A. Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides). J. Infect. Dis. 1987, 155:1011-1019.
27. Monteleone I., Pallone F., Monteleone G. Interleukin-23 and Th17 cells in the control of gut inflammation. Mediat. Inflamm. 2009, (Article ID 297645).
28. Murai M., Turovskaya O., Kim G., Madan R., Karp C.L., Cheroutre H., Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 2009, 10:1178-1184.
29. Muro, Lopez, Campilo, Salama, Martinez, Lucas, Valdes, Botella, Minguela, Miras, Carballo, Alvarez-Lopez The role of human leukocyte antigen (HLA) complex in IBD: Crohn's disease and ulcerative colitis. Adv. Stud. Biol. 2009, 1:37-41.
30. Pang Y.H., Zheng C.Q., Yang X.Z., Zhang W.J. Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients. Cell. Immunol. 2007, 248:115-120.
31. Peluso I., Pallone F., Monteleone G. Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J. Gastroenterol. 2006, 12:5606-5610.
32. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 2006, 12:1-8.
33. Polese L., Angriman I., Cecchetto A., Norberto L., Scarpa M., Ruffolo C., Barollo M., Sommariva A., D'amico D.F. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation. Eur. J. Gastroenterol. Hepatol. 2002, 14:237-241.
34. Sands B.E. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004, 126:1518-1532.
35. Selby W., Pavli P., Crotty B., Florin T., Radford-Smith G., Gibson P., Mitchell B., Connell W., Read R., Merrett M., Ee H., Hetzel D. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 2007, 132:2313-2319.
36. Smith A.M., Rahman F.Z., Hayee B.H., Graham S.J., Marks D.J.B., Sewell G.W., Palmer C.D., Wilde J., Foxwell B.M.J., Gloger I.S., Sweeting T., Marsh M., Walker A.P., Bloom S.L., Segal A.W. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 2009, 206:1883-1897.
37. Sommer S., Pudrith C., Colvin C., Coussens P. Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages. Vet. Immunol. Immunopathol. 2008, 128:44-52.
38. Strober W., Fuss I., Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007, 117:514-521.
39. Tabeta K., Yamazaki K., Akashi S., Miyake K., Kumada H., Umemoto T., Yoshie H. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect. Immun. 2000, 68:3731-3735.
40. Tan Z.Y., Bealgey K.W., Fang Y., Gong Y.M., Bao S. Interleukin-23: immunological roles and clinical implications. Int. J. Biochem. Cell Biol. 2009, 41:733-735.
41. Tremelling M., Cummings F., Fisher S.A., Mansfield J., Gwilliam R., Keniry A., Nimmo E.R., Drummond H., Onnie C.M., Prescott N.J., Sanderson J., Bredin F., Berzuini C., Forbes A., Lewis C.M., Cardon L., Deloukas P., Jewell D., Mathew C.G., Parkes M., Satsangi J. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 2007, 132:1657-1664.
42. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
43. Van Deventer S.J. Tumour necrosis factor and Crohn's disease. Gut 1997, 40:443-448.
44. Van Limbergen J., Wilson D.C., Satsangi J. The genetics of Crohn's disease. Annu. Rev. Genomics Hum. Genet. 2009, 10:89-116.
45. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
46. Zakharova M., Ziegler H.K. Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J. Immunol. 2005, 175:5024-5033.